/Bristol-Myers%20Squibb%20Co_%20NJ%20office-by%20Amy%20Lutz%20via%20Shutterstock.jpg)
Bristol-Myers Squibb Company (BMY) is one of the leading biopharmaceutical companies focused on developing treatments for diseases like cancer, inflammatory, immunologic, cardiovascular, or fibrotic diseases. With a market cap of $95.4 billion, Bristol-Myers’ operations span various countries in the Americas, Europe, and the Indo-Pacific.
The healthcare giant is expected to announce its second-quarter results before the market opens on Thursday, Jul. 31. Ahead of the event, analysts expect BMY to deliver a profit of $1.38 per share, down 33.3% from $2.07 per share reported in the year-ago quarter. On a positive note, the company has a solid earnings surprise history and has surpassed the Street’s bottom-line estimates in each of the past four quarters.